Osaic Holdings
CTSO icon

Osaic Holdings’s Cytosorbents Corp CTSO Stock Holding History

Osaic Holdings’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.2K Hold
130,419
– – ﹤0.01% 4902
2025
Q4 		$83.4K Hold
130,419
– – ﹤0.01% 4857
2025
Q3 		$122K Hold
130,419
– – ﹤0.01% 4619
2025
Q2 		$167K Sell
130,419
-33,329
-20% -$33.5K ﹤0.01% 4094
2025
Q1 		$164K Buy
163,748
+36,528
+29% +$38.5K ﹤0.01% 3794
2024
Q4 		$116K Buy
127,220
+4,800
+4% +$4.71K ﹤0.01% 4066
2024
Q3 		$184K Buy
122,420
+10,000
+9% +$11K ﹤0.01% 3719
2024
Q2 		$78.8K Sell
112,420
-1,390
-1% -$1.21K ﹤0.01% 4325
2024
Q1 		$108K Buy
113,810
+1,100
+1% +$1.07K ﹤0.01% 4188
2023
Q4 		$125K Sell
112,710
-72,572
-39% -$108K ﹤0.01% 4270
2023
Q3 		$348K Buy
185,282
+106,873
+136% +$307K ﹤0.01% 3557
2023
Q2 		$281K Buy
78,409
+153
+0.2% +$484 ﹤0.01% 3626
2023
Q1 		$264K Buy
78,256
+2,529
+3% +$7.59K ﹤0.01% 3648
2022
Q4 		$118K Buy
75,727
+960
+1% +$1.42K ﹤0.01% 4301
2022
Q3 		$101K Sell
74,767
-1,100
-1% -$2.15K ﹤0.01% 4368
2022
Q2 		$166K Buy
75,867
+932
+1% +$2.14K ﹤0.01% 3966
2022
Q1 		$1.54M Buy
74,935
+185
+0.2% +$663 ﹤0.01% 2159
2021
Q4 		$314K Sell
74,750
-1,808
-2% -$10.1K ﹤0.01% 3517
2021
Q3 		$623K Sell
76,558
-1,192
-2% -$9.68K ﹤0.01% 2810
2021
Q2 		$588K Buy
77,750
+4,200
+6% +$35.4K ﹤0.01% 2846
2021
Q1 		$639K Sell
73,550
-850
-1% -$8.1K ﹤0.01% 2627
2020
Q4 		$594K Buy
74,400
+20,390
+38% +$171K ﹤0.01% 2487
2020
Q3 		$431K Buy
54,010
+15,450
+40% +$139K ﹤0.01% 2564
2020
Q2 		$382K Sell
38,560
-5,420
-12% -$49.8K ﹤0.01% 2569
2020
Q1 		$281K Buy
+43,980
New +$222K ﹤0.01% 2581

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's CTSO Position: Q1 2026 in Review

Osaic Holdings held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 130,419 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4902.

Osaic Holdings first reported a position in CTSO in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.54M in Q1 2022. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Osaic Holdings held 130,419 shares of Cytosorbents Corp worth $74.2K as of Q1 2026.
  • Osaic Holdings left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4902 holding.
  • Osaic Holdings first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Cytosorbents Corp position peaked at $1.54M in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.